Skip to main content

Home/ Cancer/ Group items tagged medline chemotherapy

Rss Feed Group items tagged

Matti Narkia

Evaluation of active hexose correlated compound hepatic metabolism and potential for dr... - 0 views

  •  
    Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents.
    Mach CM, Fugii H, Wakame K, Smith J.
    J Soc Integr Oncol. 2008 Summer;6(3):105-9.
    PMID: 19087767
Matti Narkia

[Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of ... - 0 views

  •  
    [Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor]
    Duan P, Wang ZM.
    Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Jul;22(7):515-7. Chinese.
    PMID: 12592686
Matti Narkia

Arginine and cancer. - J Nutr. 2004 Oct - 0 views

  •  
    Arginine and cancer.
    Lind DS.
    J Nutr. 2004 Oct;134(10 Suppl):2837S-2841S; discussion 2853S. Review.
    PMID: 15465796
Matti Narkia

Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implicatio... - 0 views

  •  
    Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides.
    Elmesery ME, Algayyar MM, Salem HA, Darweish MM, El-Mowafy AM.
    Cell Div. 2009 Apr 2;4(1):6. [Epub ahead of print]
    PMID: 19341447
    doi:10.1186/1747-1028-4-6
Matti Narkia

Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC)... - 0 views

  •  
    Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate.
    Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G.
    Eur Urol. 2005 Apr;47(4):449-54; discussion 454-5. Epub 2005 Jan 19.
    PMID: 15774240
    doi:10.1016/j.eururo.2004.12.001
Matti Narkia

Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review... - 0 views

  •  
    Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials.
    Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C
    Int J Cancer. 2008 Sep 15;123(6):1227-39. Review.
    PMID: 18623084
Matti Narkia

Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs - 0 views

  •  
    Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.\nHeaney ML, Gardner JR, Karasavvas N, Golde DW, Scheinberg DA, Smith EA, O'Connor OA.\nCancer Res. 2008 Oct 1;68(19):8031-8.\nPMID: 18829561
Matti Narkia

Antiangiogenic Tetrathiomolybdate Enhances the Efficacy of Doxorubicin against Breast C... - 0 views

  •  
    Pan Q, Bao LW, Kleer CG, Brewer GJ, Merajver SD.
    Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma.
    Mol Cancer Ther. 2003 Jul;2(7):617-22.
    PMID: 12883034 [PubMed - indexed for MEDLINE]
Matti Narkia

The challenging integration of platinum compounds, taxanes, and molecular-targeted ther... - 0 views

  •  
    Awada A, Ismael G.
    The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
    Curr Opin Oncol. 2007 May;19(3):177-9.
    PMID: 17414633 [
Matti Narkia

The role of taxanes and targeted therapies in locally advanced head and neck cancer - E... - 0 views

  •  
    Specenier P, Vermorken JB.
    The role of taxanes and targeted therapies in locally advanced head and neck cancer.
    Curr Opin Oncol. 2007 May;19(3):195-201.
    PMID: 17414636 [PubMed - in process]
1 - 10 of 10
Showing 20 items per page